Teladoc HealthTDOC
TDOC
About: Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with Better convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
Employees: 5,500
0
Funds holding %
of 7,425 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
38% more first-time investments, than exits
New positions opened: 76 | Existing positions closed: 55
13% more call options, than puts
Call options by funds: $65.6M | Put options by funds: $58.3M
11% more repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 100
4% more funds holding
Funds holding: 358 [Q3] → 373 (+15) [Q4]
0.36% more ownership
Funds ownership: 73.22% [Q3] → 73.58% (+0.36%) [Q4]
0% more capital invested
Capital invested by funds: $1.15B [Q3] → $1.15B (+$2.14M) [Q4]
100% less funds holding in top 10
Funds holding in top 10: 2 [Q3] → 0 (-2) [Q4]
Research analyst outlook
9 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$7
7%
downside
Avg. target
$9.08
21%
upside
High target
$12
60%
upside
9 analyst ratings
3 positive
33%
6 neutral
67%
0 negative
0%
Wells Fargo Stan Berenshteyn 30% 1-year accuracy 3 / 10 met price target | 6%upside $8 | Equal-Weight Maintained | 8 May 2025 |
Canaccord Genuity Richard Close 43% 1-year accuracy 10 / 23 met price target | 60%upside $12 | Buy Maintained | 1 May 2025 |
Goldman Sachs David Roman 41% 1-year accuracy 9 / 22 met price target | 33%upside $10 | Buy Maintained | 1 May 2025 |
Stifel David Grossman 100% 1-year accuracy 1 / 1 met price target | 6%upside $8 | Hold Maintained | 1 May 2025 |
Evercore ISI Group Elizabeth Anderson 53% 1-year accuracy 16 / 30 met price target | 7%downside $7 | In-Line Maintained | 1 May 2025 |
Financial journalist opinion
Based on 15 articles about TDOC published over the past 30 days
Negative
Benzinga
7 hours ago
Teladoc's Outlook Clouds As JPMorgan Points To Uncertainty In Behavioral Health, Margin Pressure
JPMorgan analyst Lisa C. Gill maintained a Neutral rating on Teladoc Health, Inc TDOC on Thursday with a price target of $9, down from the prior $11.
Neutral
The Motley Fool
14 hours ago
1 Beaten-Down Stock to Buy Right Now, and 1 to Avoid
Equity markets are full of bargains -- stocks that have performed terribly in recent months, whether due to trade-related marketwide issues or company-specific troubles, but could bounce back once things improve. There are also companies that are not performing well and are unlikely to rebound anytime soon; that's the kind investors should stay away from.
Neutral
Zacks Investment Research
1 week ago
TDOC Q1 Loss Narrower Than Estimates on Strong Integrated Care Unit
Teladoc Health expects Integrated Care members to be between 101 million and 103 million in 2025.
Positive
Seeking Alpha
1 week ago
Teladoc Health: No Real Rescue In Sight
Teladoc Health needs a turnaround plan, as it lacks a growth catalyst and remains too focused on virtual mental health rather than a revolutionary telehealth technology. The virtual healthcare provider has minimal growth in chronic care enrollment where weight-loss management was supposed to drive the business. The stock is cheap, trading at 5x EV/EBITDA targets with a market cap of only $1.2 billion, but lacks sustainable growth in virtual healthcare to be a long-term investment.
Neutral
GlobeNewsWire
1 week ago
Teladoc Health Announces Employee Inducement Awards under NYSE Rule 303A.08
PURCHASE, N.Y., May 02, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued inducement awards to five new employees.
Neutral
Seeking Alpha
2 weeks ago
Teladoc Health, Inc. (TDOC) Q1 2025 Earnings Call Transcript
Teladoc Health, Inc. (NYSE:TDOC ) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ET Corporate Participants Mike Minchak - Head of Investor Relations Chuck Divita - Chief Executive Officer Mala Murthy - Chief Financial Officer Conference Call Participants Jessica Tassan - Piper Sandler David Roman - Goldman Sachs Daniel Grosslight - Citi Eduardo Ron - Truist Elizabeth Anderson - Evercore Charles Rhyee - Cowen Operator Good afternoon, thank you for attending today's Teladoc Health First Quarter 2025 Earnings Call. My name is Cole and I'll be the moderator for today's call.
Positive
Zacks Investment Research
2 weeks ago
Teladoc (TDOC) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Teladoc (TDOC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Negative
Zacks Investment Research
2 weeks ago
Teladoc (TDOC) Reports Q1 Loss, Tops Revenue Estimates
Teladoc (TDOC) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $0.49 per share a year ago.
Neutral
GlobeNewsWire
2 weeks ago
Teladoc Health Reports First Quarter 2025 Results
PURCHASE, NY, April 30, 2025 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2025 (“First Quarter 2025”). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2024 (“First Quarter 2024”).
Neutral
CNBC
2 weeks ago
Teladoc buys mental health company UpLift to help boost struggling BetterHelp unit
Teladoc Health has acquired mental health company UpLift for $30 million in cash. UpLift offers virtual mental health therapy, psychiatry and medication management services.
Charts implemented using Lightweight Charts™